The committee responsible for choosing S&P 500 components has flexibility in deciding new entrants — and this time around, it seems to be opting for relative stability over volatility. Back To Top ...
Pharmaceutical giants such as J&J, Merck, and Eli Lilly are embracing AI and prioritizing upskilling. They hope that training thousands of employees on generative AI will boost productivity in ...
Nisha Gopalan is the Senior Overnight Assignment Editor for Investopedia News. She is an award-winning financial journalist who has worked in London, where she is currently based, and Hong Kong.
Lexicon Pharmaceuticals LXRX has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the ...
Valued at a market cap of $143.8 billion, Gilead Sciences, Inc. (GILD) is a biopharmaceutical company that discovers, develops, and commercializes medicines in the areas of unmet medical need.
Tonix Pharmaceuticals shares have surged 115% since Monday’s open. Tonix this week announced data regarding its fibromyalgia treatment, TNX-102 SL. Feel unsure about the market’s next move?
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Kiniksa Pharmaceuticals, Ltd. (KNSA) shares soared 5.8% in the last trading session to close at $21.46. The move was backed by solid volume with far more shares changing hands than in a normal ...
The Department of Public Enterprises, on Monday, March 3, said it has approved the upgradation of Indian Railway Catering and Tourism Corporation (IRCTC) and Indian Railway Finance Corporation (IRFC) ...
Shares of Reliance Industries (RIL) hit an over 15-month low of Rs 1,161.40, as they slipped 3 per cent on the BSE in Monday’s intra-day trade extending its fall on the bourses on a sharp sell-off in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results